Fig. 2: Histone lysine lactylation in cancer. | Experimental & Molecular Medicine

Fig. 2: Histone lysine lactylation in cancer.

From: Protein lactylation in cancer: mechanisms and potential therapeutic implications

Fig. 2

a–d Histone lysine lactylation is related to protumorigenic gene expression (a), lincRNA and circular RNA expression (b) RNA methylation (c) and resistance to cancer therapy (d). e The histone H3 variant CENPA is lactylated to induce HCC proliferation. ABC transporter, ATP-binding cassette transporter; ALKBH3, α-ketoglutarate-dependent dioxygenase AlkB homolog 3; CCN, cyclin; circATXN7, circular RNA ataxin 7; HK1, hexokinase 1; JAK1, janus kinase 1; MDM4, murine double minute 4; METTL3, methyltransferase-like protein 3; NSUN2, NOP2/Sun RNA methyltransferase 2; PER1, period circadian clock 1; SP100A, SP100 nuclear antigen; TP53, tumor protein 53; YTHDF, YTH N6-methyladenosine RNA-binding protein; YY1, ying yang 1.

Back to article page